1. 1. Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 9: 2026-2030, 1996.
2. 2. Bilaçeroglu S, Perim K, Büyüksirin M, Celikten E. Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial. Int J Tuberc Lung Dis 3: 47-54, 1999.
3. 3. Chung KF, Snashall PD. Suppression of prolonged fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone. Postgrad Med J 59: 373-375, 1983.
4. 4. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5: 415-430, 2005.
5. 5. Umeki S. Rifampicin and pulmonary fibrosis. Arch Intern Med 148: 1663-1667, 1988.